awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48369935-BD3789A2-2B20-427C-8334-6D1C4799E3E7
Q48369935-BD3789A2-2B20-427C-8334-6D1C4799E3E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48369935-BD3789A2-2B20-427C-8334-6D1C4799E3E7
Some statistical considerations in the clinical development of cancer immunotherapies.
P2860
Q48369935-BD3789A2-2B20-427C-8334-6D1C4799E3E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48369935-BD3789A2-2B20-427C-8334-6D1C4799E3E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d3a54a0a96ab7a36b0ddfa5412facaa95b606a67
P2860
A product of independent beta probabilities dose escalation design for dual-agent phase I trials.